Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy

British Journal of Ophthalmology

Volumn 92, Issue 7, 2008, Pages 896-900

  Yamada, N ^a   Matsuda, R ^a   Morishige, N ^a   Yanai, R ^b   Chikama, T I ^b   Nishida, T ^a   Ishimitsu, T ^c   Kamiya, A ^c  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; PHENYLALANYLGLYCYLLEUCYLMETHIONINAMIDE; SERYLSERYLSERYLARGININE; SOMATOMEDIN C; SOMATOMEDIN C DERIVATIVE; SUBSTANCE P; SUBSTANCE P DERIVATIVE; TETRAPEPTIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORNEA DISEASE; CORNEA EPITHELIUM; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; HUMAN; KERATOPATHY; MALE; NEUROTROPHIC KERATOPATHY; PERSISTENT CORNEAL EPITHELIAL DEFECT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SLIT LAMP; STEM CELL; TREATMENT DURATION; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; CORNEA; CORNEAL DISEASES; DRUG COMBINATIONS; EPITHELIUM, CORNEAL; FEMALE; HUMANS; LIMBUS CORNEAE; MALE; MIDDLE AGED; OLIGOPEPTIDES; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; SENSATION DISORDERS; STEM CELLS; TEARS; TREATMENT OUTCOME; VISUAL ACUITY; WOUND HEALING;

EID: 47049108390     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.130013     Document Type: Article

References (25)

1. Nishida T. Cornea. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea, 2nd edn. St. Louis: Mosby-Year Book, 2005:3-26.
2. Davis EA, Dohlman CH. Neurotrophic keratitis. Int Ophthalmol Clin 2001;41:1-11.
3. Nishida T. Neurotrophic mediators and corneal wound healing. Ocul Surf 2005;3:194-202.
4. Rozsa AJ, Beuerman RW. Density and organization of free nerve endings in the corneal epithelium of the rabbit. Pain 1982;14:105-20.
5. Shimizu Y. Localization of neuropeptides in the cornea and uvea of the rat: an immunohistochemical study. Cell Mol Biol 1982;28:103-10.
6. Yamada M, Ogata M, Kawai M, et al. Substance P and its metabolites in normal human tears. Invest Ophthalmol Vis Sci 2002;43:2622-5.
7. Yamada M, Ogata M, Kawai M, et al. Decreased substance P concentrations in tears from patients with corneal hypesthesia. Am J Ophthalmol 2000;129:671-2.
8. Nishida T, Nakamura M, Ofuji K, et al. Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea. J Cell Physiol 1996;169:159-66.
9. Nakamura M, Ofuji K, Chikama T, et al. Combined effects of substance P and insulin-like growth factor-1 on corneal epithelial wound closure of rabbit in vivo. Curr Eye Res 1997;16:275-8.
10. 2 of the C-terminal of substance P and insulin-like growth factor-1 on epithelial wound healing of rabbit cornea. Br J Pharmacol 1999;127:489-97.
11. Soloway MR, Stjernschantz J, Sears M. The miotic effect of substance P on the isolated rabbit iris. Invest Ophthalmol Vis Sci 1981;20:47-52.
12. Brown SM, Lamberts DW, Reid TW, et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1. Arch Ophthalmol 1997;115:926-7.
13. Chikama T, Fukuda K, Morishige N, et al. Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I. Lancet 1998;351:1783-4.
14. Nishida T, Chikama T, Morishige N, et al. Persistent epithelial defects due to neurotrophic keratopathy treated with a substance P-derived peptide and insulin-like growth factor-1. Jpn J Ophthalmol 2007;51:442-7.
15. Morishige N, Komatsubara T, Chikama T, et al. Direct observation of corneal nerve fibres in neurotrophic keratopathy by confocal biomicroscopy. Lancet 1999;354:1613-14.
16. Yamada N, Yanai R, Nakamura M, et al. Role of the C domain of IGFs in synergistic promotion, with a substance P-derived peptide, of rabbit corneal epithelial wound healing. Invest Ophthalmol Vis Sci 2004;45:1125-31.
17. Yamada N, Yanai R, Inui M, et al. Sensitizing effect of substance P on corneal epithelial migration induced by IGF-1, fibronectin, or interleukin-6. Invest Ophthalmol Vis Sci 2005;46:833-9.
18. Yamada N, Yanai R, Kawamoto K, et al. Promotion of corneal epithelial wound healing by a tetrapeptide (SSSR) derived from IGF-1. Invest Ophthalmol Vis Sci 2006;47:3286-92.
19. Tsai RJ, Li LM, Chen JK. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells. N Engl J Med 2000;343:86-93.
20. Lambiase A, Rama P, Bonini S, et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N EnglJ Med 1998;338:1174-80.
21. Tsubota K, Goto E, Shimmura S, et al. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999;106:1984-9.
22. Nakamura M, Ofuji K, Chikama T, et al. The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulinlike growth factor-1. Br J Pharmacol 1997;120:547-52.
23. Nakamura M, Chikama T, Nishida T. Up-regulation of integrin α5 expression by combination of substance P and insulin-like growth factor-1 in rabbit corneal epithelial cells. Biochem Biophys Res Commun 1998;246:777-82.
24. Nakamura M, Nagano T, Chikama T, et al. Up-regulation of phosphorylation of focal adhesion kinase and paxillin by combination of substance P and IGF-1 in SV-40 transformed human corneal epithelial cells. Biochem Biophys Res Commun 1998;242:16-20.
25. Chikama T, Nakamura M, Nishida T. Up-regulation of integrin α5 by a C-terminus four-amino-acid sequence of substance P (phenylalanine-glycine-leucine-methionine-amide) synergisticaily with insulin-like growth factor-1 in SV-40 transformed human corneal epithelial cells. Biochem Biophys Res Commun 1999;255:692-7.